Eleanor Spenceley

Eleanor Spenceley

Auto-generated profile, based on publicly available information

Eleanor Spenceley

Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2026 in Nature
Verified
Journal Article
Open access
PDF file
ACAnna S. E. Cuomo
Anna S. E. Cuomo
ESEleanor Spenceley
Eleanor Spenceley
HTHope A. Tanudisastro
Hope A. Tanudisastro
BBBlake Bowen
Blake Bowen
AHAlbert Henry
Albert Henry
JPJoseph E. Powell
Joseph E. Powell
Understanding the genetic basis of gene expression can shed light on the regulatory mechanisms underlying complex traits and diseases1,2. Single-cell-resolved measures of RNA levels and single-cell expression quantitative trait loci have revealed genetic regulation that drives cell states and types across diverse tissues3. Here we describe phase 1 of TenK10K, which leverages single-cell RNA sequencing data from more than 5 million cells across 28 immune cell types, along with matched whole-genome sequencing data from 1,925 individuals. This provides power to detect associations for rare and low-frequency genetic variants that have largely been uncharacterized in their impact on cell-specific gene expression. We map the effects of both common and rare variants in a cell-type-specific manner using a recent method that increases power by modelling single cells directly rather than aggregated ‘pseudobulk’ counts. We identify putative common regulatory variants for 83% of all 21,404 genes tested and cumulative rare-variant signals for 47% of those genes. We explore how genetic effects vary across cell types and states, develop a framework to determine the degree of single-cell expression quantitative trait loci cell-type specificity and show that about half of the effects are observed only in one or a few cell types. By integrating our results with functional annotations and disease information, we further characterize the likely molecular modes of action for many disease-variant associations. Finally, we explore the effects that genetic variants have on gene expression across continuous cell states, and effects that vary cell-state abundance directly.

28 October 2026 in Nature
Verified
Journal Article
Closed access
HTHope A. Tanudisastro
Hope A. Tanudisastro
ACAnna S. E. Cuomo
Anna S. E. Cuomo
BWBen Weisburd
Ben Weisburd
MWMatthew Welland
Matthew Welland
ESEleanor Spenceley
Eleanor Spenceley
DMDaniel G. MacArthur
Daniel G. MacArthur

28 October 2026 in Nature
Verified
Journal Article
Open access
PDF file
AXAngli Xue
Angli Xue
JFJianan Fan
Jianan Fan
ODOscar A. Dong
Oscar A. Dong
HHHao Lawrence Huang
Hao Lawrence Huang
LCLing Chen
Ling Chen
JPJoseph E. Powell
Joseph E. Powell
Understanding how genetic variation shapes gene regulation at single-cell resolution is crucial for elucidating complex disease mechanisms1, but has been limited by the lack of large-scale single-cell multi-omics data2,3,4. Here we present single-cell assay for transposase-accessible chromatin with sequencing of 3.5 million peripheral blood mononuclear cells from 1,042 donors with matched whole-genome sequencing. Across 28 immune cell types, we tested 440,996 chromatin accessibility peaks and identified 243,225 chromatin accessibility quantitative trait loci (caQTLs) at 100,483 peaks, 60% of them cell-type specific. Rare variant analysis identified 38,161 associated peaks, with predicted transcription factor-binding disruption implicated at individual loci. Colocalization with expression QTLs (eQTLs) from single-cell RNA sequencing data (5.4 million peripheral blood mononuclear cells)5 defined 28,834 candidate cis-regulatory elements. Across genome-wide association studies for 16 diseases and 44 blood traits, caQTLs colocalized 4.5–22.6% more signals than eQTLs alone. Cell-type-specific and tissue-specific context, distal effects and multi-causal-variant models raised genome-wide association study–eQTL concordance from approximately 16% to approximately 65%. Cell state further modulates genetic effects, with 27% of over 200,000 caQTL–cell-state interactions lacking a main effect. At the inflammatory bowel disease risk gene ADCY7, accessibility effects varied with genotype and G protein-mediated pathway activity in CD4+ T cells. A graph neural network trained on both eQTL and caQTL layers inferred peak–gene links in unpaired multiome data with up to 17.2% higher accuracy than QTL-agnostic data, uncovering 128 additional transcription factor–target pairs (22% increase). Together, these results show that genetic variants shape chromatin accessibility in a cell-type-specific and cell-state-specific manner, influencing immune function and disease risk.

18 January 2026 in Clinical and Translational Science
Verified
Journal Article
Open access
WLWeiqian Eugene Lee
Weiqian Eugene Lee
AHAlbert Henry
Albert Henry
ESEleanor Ruth Spenceley
Eleanor Ruth Spenceley
ESEszter Sagi‐Zsigmond
Eszter Sagi‐Zsigmond
BBBlake Bowen
Blake Bowen
Gemma FigtreeGemma Figtree
Gemma Figtree
Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, and identifying accessible blood‐based biomarkers is therefore a clinical priority. Given the involvement of oxidative stress and immune cell dysfunction in atherosclerosis, we investigated whether mitochondrial reactive oxygen species (mROS) production in peripheral blood mononuclear cells (PBMCs) is associated with CAD. This exploratory study analyzed PBMCs from 40 BioHEART‐CT participants with or without CT‐defined CAD using MitoSOX‐based flow cytometry. In parallel, single‐cell RNA sequencing (scRNA‐seq) was conducted in the same individuals to investigate differential expression of CCBE1, a recently implicated gene in cardiovascular disease, across PBMC populations. Overall, mROS levels in PBMCs and their major cellular subtypes did not show consistent or meaningful associations with CAD status or with modifiable cardiovascular risk factors. Small, subgroup‐specific signals—such as moderate association between lymphocyte mROS and coronary artery calcium score in males, and a modest inverse association between monocyte mROS and hypertension—were exploratory and not uniform across analyses. scRNA‐seq analysis did not identify a distinct CCBE1 expression signature in PBMCs. These findings indicate that PBMC‐derived mROS is unlikely to serve as a useful cross‐sectional biomarker of CAD in stable populations.